Palatin Technologies INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
AuGC BioFund LP, AuGC Partners LLC, and Evan Markegard have jointly reported beneficial ownership of 4.7% of Palatin Technologies Inc. common stock.
NASDAQ
Logos Global Management LP and associated entities have filed a Schedule 13G reporting a 9.9% beneficial ownership stake in Palatin Technologies Inc.
NASDAQ
SCHEDULE: Palatin Technologies Stakeholder Filing
Sirenia Capital Management LP and Alex Silverstein report a combined 9.9% beneficial ownership in Palatin Technologies Inc., primarily through warrants.
NASDAQ
AuGC BioFund LP, AuGC Partners LLC, and Evan Markegard have filed a Schedule 13G reporting a 5.3% beneficial ownership stake in Palatin Technologies Inc.
NASDAQ
Driehaus Capital Management LLC has reported a 9.79% beneficial ownership stake in Palatin Technologies, Inc. common stock.
NASDAQ
Janus Henderson Group plc and its affiliate have reported a 9.99% beneficial ownership stake in Palatin Technologies Inc. common stock.
NASDAQ
Logos Global Management LP and its affiliates have disclosed a 9.9% beneficial ownership stake in Palatin Technologies Inc. following a recent share offering.
NASDAQ
Point72 Asset Management, along with Point72 Capital Advisors Inc. and Steven A. Cohen, reported a 9.9% beneficial ownership stake in Palatin Technologies Inc., including warrants.
NASDAQ
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, disclosing a beneficial ownership of 4.99% of Palatin Technologies Inc.'s common stock as of March 31, 2025.
NASDAQ
Armistice Capital, LLC and its managing member Steven Boyd have disclosed a beneficial ownership of 8.5% in Palatin Technologies Inc., as of December 31, 2024.